ReviewGeroScience2026
Sonic hedgehog-matrix metalloproteinase crosstalk in neurovascular ageing and stroke: a potential mechanistic link.
Review in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurovascular ageing is a major contributor to cerebrovascular vulnerability and poor stroke outcomes in older adults. Progressive deterioration of the neurovascular unit (NVU), driven by oxidative stress, neurovascular coupling dysfunction, blood-brain barrier (BBB) disruption, inflammageing, cellular senescence, mitochondrial dysfunction, and impaired autophagy compromises neurovascular resilience and increases susceptibility to ischemic injury. Among the molecular pathways implicated in these processes, Sonic hedgehog (Shh) signaling and matrix metalloproteinases (MMPs) are important regulators of neurovascular remodeling, BBB integrity, and post-stroke recovery. Although these pathways have largely been investigated independently, emerging evidence suggests potential bidirectional interactions between Shh signaling and MMP activity. In particular, Shh/Gli1 signaling has been associated with regulation of MMP-2 and MMP-9 in experimental models, whereas MMP-2 can disrupt SCUBE2, an extracellular regulator of Shh ligand presentation, providing a potential mechanism for reciprocal pathway modulation. This review examines the Shh-MMP axis as a potential mechanistic link between neurovascular ageing and ischemic vulnerability, integrating current evidence to evaluate how dysregulation of these pathways may contribute to BBB dysfunction, extracellular matrix remodeling, neuroinflammation, and impaired neurovascular repair. We further discuss the potential therapeutic implications of modulating the Shh-MMP axis to preserve neurovascular resilience and improve cerebrovascular outcomes in the ageing brain, while highlighting the importance of temporal and cell-specific targeting.
Indexed as
Identifiers
42945031What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.